Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives
R. Tandon, J. S. Sharp, F. Zhang, V. H. Pomin, N. M. Ashpole, D. Mitra, W. Jin, H. Liu, P. Sharma, R. J. Linhardt
This study evaluates the antiviral activity of heparin and enoxaparin derivatives against SARS-CoV-2 by testing their ability to neutralize pseudotyped virus particles.
bioRxiv · Jun 8, 2020Microbiology